The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Determining agreement between immunohistochemistry and RT-qPCR for standard biomarkers in breast cancer: Validation on GEICAM 9906 clinical trial.
P. S. Bernard
Employment or Leadership Position - University Genomics (U)
Consultant or Advisory Role - University Genomics (U)
Stock Ownership - University Genomics
C. Davis
No relevant relationships to disclose
B. Munarriz
No relevant relationships to disclose
I. J. Stijleman
No relevant relationships to disclose
M. Ruiz-Borrego
No relevant relationships to disclose
M. T. W. Ebbert
Employment or Leadership Position - ARUP Laboratories
A. Rodriguez-Lescure
Research Funding - Bristol-Myers Squibb
R. R. L. Bastien
Employment or Leadership Position - ARUP Laboratories
C. Crespo
No relevant relationships to disclose
C. M. Perou
Employment or Leadership Position - University Genomics (U)
Consultant or Advisory Role - University Genomics (U)
Stock Ownership - University Genomics
C. Rodriguez
No relevant relationships to disclose
F. I. Aranda
No relevant relationships to disclose
V. FuriĆ³
No relevant relationships to disclose
I. Alvarez
No relevant relationships to disclose
M. A. SeguĆ­
No relevant relationships to disclose
E. Alba
No relevant relationships to disclose
A. Anton
No relevant relationships to disclose
E. M. Carrasco
Stock Ownership - Lilly
R. Caballero
No relevant relationships to disclose
M. Martin
Research Funding - Bristol-Myers Squibb; Pfizer